Latest Financial Results News

Amotiv Limited’s interim results reveal a 34.3% decline in net profit despite a 2.3% revenue increase, driven by significant impairments and restructuring costs. The company declared a fully franked interim dividend of 18.5 cents per share.

Commonwealth Bank of Australia announces a fully franked ordinary dividend of AUD 2.25 per share, payable March 28, 2025, reflecting solid financial results for the period ending December 31, 2024.

Commonwealth Bank of Australia reported a robust 8% increase in net profit after tax for the half year ended December 2024, underpinned by higher revenue and disciplined credit management. The bank declared a fully franked interim dividend of 225 cents per share, reflecting confidence amid economic headwinds.

SIV Capital Limited reported a sharp increase in losses for the half-year ending December 2024 and remains suspended from ASX trading due to operational concerns. The company is exploring acquisitions to leverage substantial tax losses and restore market confidence.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.

Computershare delivered a robust 1H25 performance with an 18.7% rise in management EPS and a 12.5% increase in interim dividends, prompting an upgraded FY25 earnings outlook.

BKI Investment Company Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.039 per share and providing key details on its Dividend Reinvestment Plan (DRP).

Tamawood Limited has reported a steady increase in revenue and profit for the half year ended December 31, 2024, signaling ongoing resilience in the residential construction sector.

Ryder Capital Limited reports a robust $13.02 million total comprehensive income for 1H FY25, driving a 12.5% increase in its fully franked interim dividend to 4.5 cents per share.

Light & Wonder, Inc. has amended its credit agreement to increase its revolving credit facility from $750 million to $1 billion, extend the maturity to 2030, and reduce interest margins based on leverage tests, enhancing its financial flexibility.

SomnoMed Limited prepares to unveil its H1FY25 financial results on February 28, 2025, accompanied by a live investor presentation and Q&A session. The company remains a global leader in sleep apnea treatment solutions.

Ramsay Health Care has announced a significant $305 million impairment in its UK segment driven by challenges at Elysium, alongside a $64.5 million tax provision release linked to Ramsay Santé. The company is taking decisive steps to address operational weaknesses while its core UK hospitals show promising growth.